Average Co-Inventor Count = 7.42
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Oncoarendi Therapeutics S.a. (8 from 8 patents)
2. Boehringer Ingelheim International Gmbh (2 from 1,535 patents)
3. Oncoarendi Therapeutics Sp. Z O.o. (2 from 2 patents)
4. Molecure S.a. (1 from 5 patents)
5. Instytut Biochemii I Biofizyki Polskiej Akademii Nauk (1 from 3 patents)
6. Institute for Drug Discovery, LLC (1 from 1 patent)
7. Miedzynarodowy Instytut Biologii Molekularnej I Komorkowej W Warszawie (1 from 1 patent)
14 patents:
1. 12053451 - Arginase inhibitors and their therapeutic applications
2. 11638707 - Substituted amino triazoles useful as chitinase inhibitors
3. 10912755 - Arginase inhibitors and their therapeutic applications
4. 10851099 - Dipeptide piperidine derivatives
5. 10538508 - Substituted amino triazoles useful as human chitinase inhibitors
6. 10391077 - Arginase inhibitors and their therapeutic applications
7. 10329310 - Arginase inhibitors and their therapeutic applications
8. 10214531 - Substituted amino triazoles, and methods using same
9. 10208020 - Substituted amino triazoles useful as human chitinase inhibitors
10. 9944624 - Substituted amino triazoles useful as human chitinase inhibitors
11. 9611514 - Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment
12. 9440953 - Substituted amino triazoles useful as acidic mammalian chitinase inhibitors
13. 8354407 - 2-anilino-4-(heterocyclic)amino-pyrimidines
14. 8158641 - 2-anilino-4-aminoalkyleneaminopyrimidines